Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -225.12% is 29% above its 2-year average of -315.26%, near the high end of its 2-year range (-437.44%–-225.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.43% above its 12-month average of -254.17%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -225.12%.
RETURN ON INVESTED CAPITAL (ROIC)
-225.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-254.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+11.43%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 666 covered companies
CURRENT VS SECTOR MEDIAN
-574.32%
vs the sector median at left
Liminatus Pharma, Inc. Class A Common Stock
Market Cap
$5.16M
Return on Invested Capital (ROIC)
-225.12%
TTM Avg
-254.17%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.19M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-67.32%
3Y Avg
-73.33%
5Y Avg
-73.33%
Market Cap
$5.22M
Return on Invested Capital (ROIC)
-160.81%
TTM Avg
-121.99%
3Y Avg
-86.44%
5Y Avg
-69.30%
Market Cap
$5.27M
Return on Invested Capital (ROIC)
-179.58%
TTM Avg
-259.96%
3Y Avg
-220.56%
5Y Avg
-170.22%
Market Cap
$5.04M
Return on Invested Capital (ROIC)
-126.69%
TTM Avg
-289.57%
3Y Avg
-198.60%
5Y Avg
-147.26%
Market Cap
$5.29M
Return on Invested Capital (ROIC)
-156.69%
TTM Avg
-654.50%
3Y Avg
-599.09%
5Y Avg
-420.09%
Market Cap
$5.01M
Return on Invested Capital (ROIC)
-35.07%
TTM Avg
-9.54%
3Y Avg
2.54%
5Y Avg
2.54%
Market Cap
$5.32M
Return on Invested Capital (ROIC)
-27.41%
TTM Avg
-21.46%
3Y Avg
-17.98%
5Y Avg
-12.44%
Market Cap
$4.94M
Return on Invested Capital (ROIC)
-122.56%
TTM Avg
-179.66%
3Y Avg
-275.36%
5Y Avg
-182.57%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $5.16M | -225.12% | -254.17% | N/A | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | N/A | -67.32% | -73.33% | -73.33% |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | -160.81% | -121.99% | -86.44% | -69.30% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | -179.58% | -259.96% | -220.56% | -170.22% |
| Imunon, Inc. (IMNN)vs › | $5.04M | -126.69% | -289.57% | -198.60% | -147.26% |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | -156.69% | -654.50% | -599.09% | -420.09% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | -35.07% | -9.54% | 2.54% | 2.54% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | -27.41% | -21.46% | -17.98% | -12.44% |
| CalciMedica, Inc. (CALC)vs › | $4.94M | -122.56% | -179.66% | -275.36% | -182.57% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.51M | -94.08% | -1223.16% | -731.00% | -532.24% |
ROIC
-225.1%
ROE
-4165.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -225.12% |
| 2026-03-31 | -283.21% |
| 2024-06-30 | -437.44% |
